FDA issued its first DSCSA Form 483 to a physician-owned practice in 2026

  • Home
  • Practice Speciality
    • MedSpa
    • EyeCare
    • Oncology
    • Rhuematology
    • Dispensary / Pharmacy
    • Primary Care
  • What We Do
  • How It Works
  • Video's Blog & Articles
  • FAQ
  • Contact US
  • Assessment - Free
  • More
    • Home
    • Practice Speciality
      • MedSpa
      • EyeCare
      • Oncology
      • Rhuematology
      • Dispensary / Pharmacy
      • Primary Care
    • What We Do
    • How It Works
    • Video's Blog & Articles
    • FAQ
    • Contact US
    • Assessment - Free
  • Home
  • Practice Speciality
    • MedSpa
    • EyeCare
    • Oncology
    • Rhuematology
    • Dispensary / Pharmacy
    • Primary Care
  • What We Do
  • How It Works
  • Video's Blog & Articles
  • FAQ
  • Contact US
  • Assessment - Free

How It Works

Step 1 - Intake & Scope Confirmation

A brief intake will confirm the practice type, address Rx handling in accordance with FDA compliance, and review the scope related to the Drug Supply Chain Act (DSCSA) for RX and pharmaceutical drugs.

Step 2 - Review & Analysis

Off-site review of vendor records, purchasing data, and operational documentation is essential for ensuring compliance with the Drug Supply Chain Act (DSCSA) and meeting FDA compliance standards, especially in the context of a Medical Audit involving RX and Pharmaceutical Drugs.

Step 3 - Findings Summary

Clear identification of exposure areas tied to current enforcement behavior related to the Drug Supply Chain Act (DSCSA) is crucial for ensuring FDA compliance in the handling of RX and pharmaceutical drugs, particularly during a medical audit.

Step 4 - Remediation Roadmap

We provide prioritized, actionable recommendations that align with inspection expectations, ensuring compliance with the Drug Supply Chain Act (DSCSA) and FDA compliance requirements for RX and pharmaceutical drugs during a medical audit.

Engagement Flow

1. Intake & Scope Confirmation

Confirm practice type, Rx handling activities, and review scope.

2. Remote Review & Analysis

Review vendor records, purchasing data, and operational documentation off-site.

3. Findings Summary

Identify exposure areas tied to inspection and documentation expectations.

4. Remediation Roadmap

Provide prioritized, actionable recommendations aligned to enforcement behavior.

Engagement Characteristics

  • Remote and time-bounded
  • No required software or system changes
  • Independent and vendor-neutral

  • Video's Blog & Articles
  • FAQ
  • Assessment - Free

Claritas Axis Group

Copyright © 2026 claritasaxis.com - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept